Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180721 · ClinicalTrials.gov registry record · NA
A Multi-level Intervention to Increase Access and Use of the Patient Portal
A NA study of Diabetes Mellitus, Type 2 and Patient Education, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 2
- Study locations
NCT05180721: Completed NA study of Diabetes Mellitus, Type 2 and Patient Education, sponsored by Yale University.
NCT05180721 is a NA study of Diabetes Mellitus, Type 2 and Patient Education that has completed, run by Yale University. The registered enrollment target is 26 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05180721, a NA study of Diabetes Mellitus, Type 2 and Patient Education, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to develop and evaluate a multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).
Primary Outcome
Frequency. Mean portal login days/per month will be calculated using the EMR system
Conditions Studied
Interventions
- BEHAVIORAL Use of patient portal for diabetes management
Study Locations (2)
Connecticut
- Fair Haven Community Health Center - New Haven
- Norwalk Community Health Center - Norwalk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-10-03 |
| Est. Completion | 2024-07-02 |
| Phase | NA |
What the finished NCT05180721 record still lists
NCT05180721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Use of patient portal for diabetes management is the first listed.
NCT05180721 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05180721 about?
NCT05180721 is a clinical study titled "A Multi-level Intervention to Increase Access and Use of the Patient Portal". The purpose of the study is to develop and evaluate a multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).
What is the current status of trial NCT05180721?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-10-03. Estimated completion is 2024-07-02.
What conditions does trial NCT05180721 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Patient Education.
What interventions are being tested in trial NCT05180721?
The interventions under investigation include: Use of patient portal for diabetes management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05180721?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05180721 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05180721's enrollment target sits among peer trials
26 306th of 348 higher than 42 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI